GRAIL

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

Butterfly iQ3 is a handheld, whole-body ultrasound device that provides clear and detailed images for a variety of medical applications. It is the third-generation probe from Butterfly Network, and it features double the processing power and clearer images than its predecessors. Butterfly iQ3 is also equipped with real-time AI, which can help clinicians to identify and diagnose medical conditions more quickly and accurately. The device is lightweight and portable, making it easy to use in a variety of settings, including the clinic, the hospital, and the field. Butterfly iQ3 is a valuable tool for clinicians who want to improve the quality of care they provide to their patients.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.

Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.

Viz.ai is a leading provider of AI-powered care coordination solutions for healthcare providers. Its comprehensive platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions cover a wide range of therapeutic areas, including neurology, cardiology, vascular medicine, trauma, and radiology. The company's mission is to improve patient outcomes by closing the gaps between patients, clinicians, and life-saving treatments.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Accuray Incorporated is a radiation oncology company that develops, manufactures, and sells radiation therapy systems and software for the treatment of cancer. Accuray's products are used by radiation oncologists to deliver precise and effective radiation therapy treatments to patients with a variety of cancers, including prostate cancer, breast cancer, lung cancer, and brain cancer. Accuray's mission is to expand the curative power of radiation therapy to improve as many lives as possible.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

Variational AI is a company that uses generative AI to discover novel drug-like small molecules with optimized properties for defined targets. Their platform, Enki™, is the first commercially accessible foundation model for small molecules. It is designed to make generating novel molecule structures easy, with no data required. Users simply define their target product profile (TPP) and Enki does the rest. Enki is an ensemble of generative algorithms trained on decades worth of experimental data with proven results. The company was founded in September 2019 and is based in Vancouver, BC, Canada.

Proscia is a leading provider of digital pathology solutions for the modern laboratory. Its flagship product, Concentriq, is an enterprise pathology platform that enables anatomic pathology laboratories to achieve 100% digitization and deliver faster, more precise results. Proscia also offers a range of AI applications that can be used to automate tasks, improve diagnostic accuracy, and accelerate research. The company's mission is to perfect cancer diagnosis with intelligent software that changes the way the world practices pathology.

Iterative Health is a company that is dedicated to providing world-class GI care and treatment to patients around the world. They are on a mission to bring world-class care and treatment to patients around the world. Advances in machine learning and artificial intelligence are helping them create a complete GI ecosystem with the power to turn this vision into reality.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

FutureKid.ai is an AI-powered application that allows users to generate pictures of their future kids using just one image of each parent. The application uses advanced AI algorithms to create realistic HD images that provide a glimpse into the user's future family. The process is automated, ensuring user privacy by deleting all data from servers within 24 hours. FutureKid.ai is a German-based company that values user privacy and offers a unique way to visualize potential future offspring.

Galleri is a multi-cancer early detection test that uses a single blood draw to screen for over 50 types of cancer. It is recommended for adults aged 50 or older who are at an elevated risk for cancer. Galleri is not a diagnostic test and does not detect all cancers. A positive result requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it is more treatable and potentially curable. GRAIL's Galleri® test is a first-of-its-kind multi-cancer early detection (MCED) test that can detect a signal shared by more than 50 cancer types and predict the tissue type or organ associated with the signal to help healthcare providers determine next steps.

SeeYourBabyAI is an AI-powered platform that offers a unique service to predict the appearance of your future baby based on photos of you and your partner. By leveraging advanced AI technology, the platform generates realistic images of potential sons and daughters with a high level of accuracy. Users can upload their photos, receive multiple AI-generated baby photos, and share them with family and friends. The platform focuses on precision, respects ethnic backgrounds, ensures privacy through encryption, and provides high-resolution, realistic photos for a one-time payment. SeeYourBabyAI aims to provide users with a heartwarming and fun experience of visualizing their future children.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Celayix is an employee scheduling software and workforce management solution that helps businesses streamline scheduling, time and attendance tracking, and team communication. It offers tools tailored to industries such as security, healthcare, hospitality, and more, to ensure accurate and reliable scheduling. Celayix aims to save time, money, and improve employee satisfaction by simplifying workforce management processes.

HappyMama is an AI tool designed to provide instant answers to pregnancy-related questions. Users can interact with HappyMama by typing messages to start a conversation. The tool aims to offer support and guidance to expectant mothers by addressing their queries and concerns in a timely manner. For any further inquiries, users can contact HappyMama via email at [email protected].

Painfinder.co is a website that provides information and resources related to pain management. It offers a variety of articles, tips, and tools to help individuals better understand and cope with different types of pain. The platform aims to educate users on the causes of pain, various treatment options, and strategies for pain relief. With a user-friendly interface, Painfinder.co serves as a valuable resource for those seeking to improve their quality of life by managing and alleviating pain effectively.

Abridge is an AI tool designed for clinical conversations in healthcare settings. It transforms patient-clinician interactions into contextually aware, clinically useful, and billable AI-generated notes in real time. The platform is trusted by the largest healthcare systems and aims to measurably improve outcomes for clinicians, nurses, and revenue cycle teams at scale.

Ubie is a medical AI application that offers a symptom checker and helps users find possible causes for their symptoms. Developed by doctors, Ubie's AI-powered system generates a free report on potential causes based on a personalized questionnaire. The platform provides user-friendly and straightforward interface, written in layman's language, making it easy for users to navigate and understand. Ubie aims to provide a healthcare guide for everyone, offering services in Japan, the United States, and other countries worldwide.

Suki AI is an AI-powered healthcare assistant that offers ambient documentation, clinical reasoning, assisted coding, and compliance solutions for clinicians. It provides a robust SDK and suite of APIs for integrating AI capabilities into healthcare applications. Suki aims to reduce the burden of documentation, allowing clinicians to focus on patient care. The platform is fully integrated with major enterprise EHR systems and ensures safe, clinician-reviewed documentation. Suki has a high adoption rate and delivers proven ROI by increasing coding accuracy and clinician efficiency.

AskEllyn.ai is a supportive platform designed to provide knowledge, wisdom, and advice for individuals diagnosed with breast cancer. The website offers a range of resources, including a chatbot named AskEllyn, which serves as a non-medical AI companion to offer empathetic support and guidance to breast cancer survivors. The platform aims to empower users to self-advocate and navigate their cancer journey with confidence and understanding. AskEllyn is a judgment-free and multilingual digital friend that is available for free through The Lyndall Project, a non-profit organization dedicated to enhancing the patient experience through AI-powered conversational care.

The website provides detailed information for beginners on selecting a nursing school, including points to consider, advantages and disadvantages of attending school, and what to study at nursing schools. It covers topics such as the curriculum, practical skills, and the importance of selecting a school based on personal goals and desired qualifications. The site also discusses the availability of dormitories, the purpose of nursing education, and the importance of clarifying learning goals and qualifications when choosing a nursing school.

CareOasis is a platform dedicated to empowering family caregivers by providing them with the necessary resources and support. The platform offers personalized assistance, professional training, and compensation to help caregivers deliver the best care possible while also getting paid. CareOasis simplifies the process for caregivers to check their eligibility, get enrolled and certified, and start receiving regular paychecks for the care they provide. The platform aims to ease the burden on family caregivers and ensure they have the tools and support needed to continue delivering high-quality care to their loved ones.

Leny.ai is an AI-powered medical assistant designed to provide instant support to medical professionals and patients. It offers features such as differential diagnosis, treatment plan drafting, discharge instructions, referral letters, and lab value analysis. Leny.ai aims to streamline healthcare processes, save time, and provide reliable and accurate medical information. The platform is still in beta mode and continuously improving to offer more accurate responses. It is focused on data security and privacy, although not currently HIPAA compliant. Leny.ai is free of charge at present and plans to transition to a subscription-based model in the future.

Medical Chat is an advanced AI assistant designed for healthcare professionals, providing instant and accurate medical answers for both human and veterinary medicine. Its capabilities include diagnosing medical conditions, generating differential diagnosis reports, creating patient-specific clinic plans, and offering comprehensive drug information. Medical Chat utilizes the latest LLM models, including ChatGPT 3.5 and 4.0, to deliver reliable and up-to-date medical knowledge. The platform also features a vast database of professional medical textbooks, veterinary books, and PubMed articles, ensuring evidence-based responses. With its HIPAA compliance and commitment to data privacy, Medical Chat empowers healthcare providers to enhance their diagnostic capabilities and improve patient outcomes.

Coverletter.app is an AI-powered tool that helps job seekers create personalized, professional cover letters. The tool uses advanced AI technology to analyze a user's resume and the job description to generate a custom-tailored cover letter that highlights the user's skills and experience. Coverletter.app also offers a range of features to help users stand out from the competition, including the ability to customize their cover letter, get feedback from AI, and access real-life examples.

SymptomChecker.io is an AI-powered medical symptom checker that allows users to describe their symptoms in their own words and receive non-reviewed AI-generated responses. It is important to note that this tool is not intended to offer medical advice, diagnosis, or treatment and should not be used as a substitute for professional medical advice. In the case of a medical emergency, please contact your physician or dial 911 immediately.

Mediscribe Pro is an AI-powered medical scribe and documentation tool designed for healthcare professionals. It utilizes advanced medical language models and artificial intelligence to generate medical dictations, transcriptions, and chart notes. Mediscribe Pro is HIPAA and PIPEDA compliant, ensuring the security and privacy of user data. The tool offers a range of features to streamline medical documentation, including a library of 100+ medical templates, voice-activated note-taking, and seamless integration with existing EMR systems. Mediscribe Pro is designed to reduce administrative burden, improve efficiency, and enhance patient care by allowing clinicians to spend more time with patients and focus on providing quality care.

Eczemaless is an AI-powered eczema management app that helps users track and manage their condition. The app offers a variety of features, including eczema severity scoring, real-time weather alerts, food tracking, user-friendly graphs, and customized care routines. Eczemaless is available in five languages and has been downloaded over 15,000 times.

SOAPME.AI is an AI-powered SAAS application that helps clinicians generate accurate and efficient SOAP notes from patient conversations. With its HIPAA-compliant technology, SOAPME ensures fast and secure note-taking, allowing clinicians to focus more on patient care and reduce administrative burden.

Butterfly iQ3 is a handheld, whole-body ultrasound device that provides clear and detailed images for a variety of medical applications. It is the third-generation probe from Butterfly Network, and it features double the processing power and clearer images than its predecessors. Butterfly iQ3 is also equipped with real-time AI, which can help clinicians to identify and diagnose medical conditions more quickly and accurately. The device is lightweight and portable, making it easy to use in a variety of settings, including the clinic, the hospital, and the field. Butterfly iQ3 is a valuable tool for clinicians who want to improve the quality of care they provide to their patients.

Accuray Incorporated is a radiation oncology company that develops, manufactures, and sells radiation therapy systems and software for the treatment of cancer. Accuray's products are used by radiation oncologists to deliver precise and effective radiation therapy treatments to patients with a variety of cancers, including prostate cancer, breast cancer, lung cancer, and brain cancer. Accuray's mission is to expand the curative power of radiation therapy to improve as many lives as possible.

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.